相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Appraisal of immunoglobulin free light chain as a marker of response
Angela Dispenzieri et al.
BLOOD (2008)
Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma
Angela Dispenzieri et al.
BLOOD (2008)
Role of genetics in prognostication in myeloma
Herve Avet-Loiseau
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2007)
Genetic events in the pathogenesis of multiple myeloma
W. J. Chng et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2007)
Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma
David Gonzalez et al.
BLOOD (2007)
High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis
Frits van Rhee et al.
BLOOD (2007)
Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma
Marie-Christine Kyrtsonis et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome
Herve Avet-Loiseau et al.
BLOOD (2007)
Analysis of genetic abnormalities provides insights into genetic evolution of hyperdiploid myeloma
Wee J. Chng et al.
GENES CHROMOSOMES & CANCER (2006)
Competence and competition:: the challenge of becoming a long-lived plasma cell
Andreas Radbruch et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Immunoglobulin free light chains and solitary plasmacytoma of bone
David Dingli et al.
BLOOD (2006)
Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation
A Dispenzieri et al.
BLOOD (2006)
Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and-17p13 in myeloma patients treated with high-dose therapy
MA Gertz et al.
BLOOD (2005)
Molecular pathogenesis and a consequent classification of multiple myeloma
PL Bergsagel et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
International staging system for multiple myeloma
PR Greipp et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Diagnostic performance of quantitative κ and λ free light chain assays in clinical practice
JA Katzmann et al.
CLINICAL CHEMISTRY (2005)
Regulation of plasma-cell development
M Shapiro-Shelef et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Immunologic basis for the rare occurrence of true nonsecretory plasma cell dyscrasias
C Decourt et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
The generation of antibody diversity through somatic hypermutation and class switch recombination
ZQ Li et al.
GENES & DEVELOPMENT (2004)
Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance
SV Rajkumar et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Drug therapy: Multiple myeloma
RA Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Light-chain only multiple myeloma is due to the absence of functional (productive) rearrangement of the IgH gene at the DNA level
F Magrangeas et al.
BLOOD (2004)
The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma
R Fonseca et al.
BLOOD (2003)
Clinical and biologic implications of recurrent genomic aberrations in myeloma
R Fonseca et al.
BLOOD (2003)
Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization-defined chromosome 13 deletion in multiple myeloma: early results of total therapy II
J Shaughnessy et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Review of 1027 patients with newly diagnosed multiple myeloma
RA Kyle et al.
MAYO CLINIC PROCEEDINGS (2003)
Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation
H Avet-Loiseau et al.
BLOOD (2002)
分享论文
